Stocks · Health care · Biological Products, (No Diagnostic Substances)

Krystal Biotech, Inc.

KRYS Clue Score76

United States Fiscal year ends December CIK 0001711279 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Dino A Rossi

14 Aug 2026

Director

Sell

$333.23

$13.33K

Dino A Rossi

14 Aug 2026

Director

Sell

3,095

$331.43

$1.03M

Dino A Rossi

14 Aug 2026

Director

Sell

4,896

$330.36

$1.62M

Dino A Rossi

14 Aug 2026

Director

Sell

7,428

$329.60

$2.45M

Dino A Rossi

14 Aug 2026

Director

Sell

1,687

$328.52

$554.21K

Dino A Rossi

14 Aug 2026

Director

Sell

5,226

$327.39

$1.71M

Dino A Rossi

14 Aug 2026

Director

Sell

2,287

$326.60

$746.94K

Dino A Rossi

14 Aug 2026

Director

Sell

341

$325.60

$111.03K

Showing 250 of 572 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 160

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 341

Sales straight out of an exercise 68

Sales at will 150

Transactions with no price 0

Shares from compensation/vesting 1,370,174

Sales filed before the plan box existed 121

History held since 25 Sep 2017